FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

New Endpoint Option for Alcohol Use Disorder

CDER posts a drug development qualifying tool to support treatments for alcohol use disorder products.

Biologics

Clinical Hold on Moderna Norovirus Vaccine

FDA places a clinical hold on a Phase 3 study evaluating Modernas trivalent vaccine against norovirus (mRNA-1403) after a case of Guillain-Barr syndro...

latest-news-card-1
Biologics

FDA OKs Sanofis Merilog, a Novolog Biosimilar

FDA approves Sanofi-Aventis Merilog (insulin-aspart-szjj) as a biosimilar to Novo Nordisks Novolog (insulin aspart) for improving glycemic control in ...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella Heart Pumps

Abiomed recalls its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps to update their use instructions due to a risk that t...

latest-news-card-1
Human Drugs

FDA Still Faster than EMA on Cancer Approvals

A Friends of Cancer Research study update says FDA continues to review and approve novel cancer drugs faster than the European Medicines Agency.

latest-news-card-1
Biologics

Sanofi/J&J Scrap E. Coli Vaccine Candidate

Sanofi and Johnson & Johnson stop the development of their vaccine candidate for extraintestinal pathogenic E. coli because Phase 3 data show that it ...

latest-news-card-1
Human Drugs

Court Rules for FDA in Vanda Label Case

The DC District Court rules for FDA in a Vanda Pharmaceuticals lawsuit seeking an agency order to revoke the approval of a Teva ANDA for a generic cop...

Human Drugs

More Accelerated Approval Changes Needed: Kaiser

The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated approval pathway.

latest-news-card-1
Human Drugs

Astellas Wins Revised Label for Izervay

FDA approves an Astellas Pharma supplemental NDA for Izervay (avacincaptad pegol intravitreal solution) that revises the labeling for the drugs use in...

latest-news-card-1
Human Drugs

Petition Seeks FDA Leukeran Actions

A Buchannan Ingersoll petition asks FDA to impose conditions on ANDAs for generic forms of the cancer drug Leukeran.